171 related articles for article (PubMed ID: 27556085)
1. Antireflux versus conventional self-expanding metallic Stents (SEMS) for distal esophageal cancer: results of a multicenter randomized trial.
Coron E; David G; Lecleire S; Jacques J; Le Sidaner A; Barrioz T; Coumaros D; Volteau C; Vedrenne B; Bichard P; Boustière C; Touchefeu Y; Brégeon J; Prat F; Le Rhun M;
Endosc Int Open; 2016 Jun; 4(6):E730-6. PubMed ID: 27556085
[TBL] [Abstract][Full Text] [Related]
2. A phase III, multicenter, prospective, single-blinded, noninferiority, randomized controlled trial on the performance of a novel esophageal stent with an antireflux valve (with video).
Dua KS; DeWitt JM; Kessler WR; Diehl DL; Draganov PV; Wagh MS; Kahaleh M; Wong Kee Song LM; Khara HS; Khan AH; Aburajab MM; Ballard D; Forsmark CE; Edmundowicz SA; Brauer BC; Tyberg A; Buttar NS; Adler DG
Gastrointest Endosc; 2019 Jul; 90(1):64-74.e3. PubMed ID: 30684601
[TBL] [Abstract][Full Text] [Related]
3. Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial.
Homs MY; Wahab PJ; Kuipers EJ; Steyerberg EW; Grool TA; Haringsma J; Siersema PD
Gastrointest Endosc; 2004 Nov; 60(5):695-702. PubMed ID: 15557944
[TBL] [Abstract][Full Text] [Related]
4. An antireflux stent versus conventional stents for palliation of distal esophageal or cardia cancer: a randomized clinical study.
Wenger U; Johnsson E; Arnelo U; Lundell L; Lagergren J
Surg Endosc; 2006 Nov; 20(11):1675-80. PubMed ID: 16960663
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of a newly designed antireflux valve metal stent to reduce duodenobiliary reflux in patients with unresectable distal malignant biliary obstruction: a randomized, controlled pilot study (with videos).
Lee YN; Moon JH; Choi HJ; Choi MH; Lee TH; Cha SW; Cho YD; Choi SY; Lee HK; Park SH
Gastrointest Endosc; 2016 Feb; 83(2):404-12. PubMed ID: 26385187
[TBL] [Abstract][Full Text] [Related]
6. Antireflux stents for palliation of malignant esophagocardial stenosis.
Schoppmeyer K; Golsong J; Schiefke I; Mössner J; Caca K
Dis Esophagus; 2007; 20(2):89-93. PubMed ID: 17439590
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux.
Laasch HU; Marriott A; Wilbraham L; Tunnah S; England RE; Martin DF
Radiology; 2002 Nov; 225(2):359-65. PubMed ID: 12409567
[TBL] [Abstract][Full Text] [Related]
8. Management of malignant stricture of the esophagogastric junction with a newly designed self-expanding metal stent with an antireflux mechanism.
Shim CS; Jung IS; Cheon YK; Ryu CB; Hong SJ; Kim JO; Cho JY; Lee JS; Lee MS; Kim BS
Endoscopy; 2005 Apr; 37(4):335-9. PubMed ID: 15824943
[TBL] [Abstract][Full Text] [Related]
9. WITHDRAWN: Interventions for dysphagia in oesophageal cancer.
Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
Cochrane Database Syst Rev; 2011 Feb; (2):CD005048. PubMed ID: 21328271
[TBL] [Abstract][Full Text] [Related]
10. Interventions for dysphagia in oesophageal cancer.
Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
Cochrane Database Syst Rev; 2009 Oct; (4):CD005048. PubMed ID: 19821338
[TBL] [Abstract][Full Text] [Related]
11. Antireflux stent versus conventional stent in the palliation of distal esophageal cancer. A randomized, multicenter clinical trial.
Blomberg J; Wenger U; Lagergren J; Arnelo U; Agustsson T; Johnsson E; Toth E; Lagergren P
Scand J Gastroenterol; 2010; 45(2):208-16. PubMed ID: 19968614
[TBL] [Abstract][Full Text] [Related]
12. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life.
Madhusudhan C; Saluja SS; Pal S; Ahuja V; Saran P; Dash NR; Sahni P; Chattopadhyay TK
Dis Esophagus; 2009; 22(4):331-6. PubMed ID: 19473211
[TBL] [Abstract][Full Text] [Related]
13. Antireflux covered metal stent for nonresectable distal malignant biliary obstruction: Multicenter randomized controlled trial.
Hamada T; Isayama H; Nakai Y; Iwashita T; Ito Y; Mukai T; Yagioka H; Saito T; Togawa O; Ryozawa S; Hirano K; Mizuno S; Yamamoto N; Kogure H; Yasuda I; Koike K
Dig Endosc; 2019 Sep; 31(5):566-574. PubMed ID: 30803046
[TBL] [Abstract][Full Text] [Related]
14. Superiority of anti-reflux stent compared with conventional stents in the palliative management of patients with cancer of the lower esophagus and esophago-gastric junction: results of a randomized clinical trial.
Power C; Byrne PJ; Lim K; Ravi N; Moore J; Fitzgerald T; Keeling PW; Reynolds JV
Dis Esophagus; 2007; 20(6):466-70. PubMed ID: 17958720
[TBL] [Abstract][Full Text] [Related]
15. Randomised comparison of the FerX Ella antireflux stent and the ultraflex stent: proton pump inhibitor combination for prevention of post-stent reflux in patients with esophageal carcinoma involving the esophago-gastric junction.
Sabharwal T; Gulati MS; Fotiadis N; Dourado R; Botha A; Mason R; Adam A
J Gastroenterol Hepatol; 2008 May; 23(5):723-8. PubMed ID: 18410607
[TBL] [Abstract][Full Text] [Related]
16. Anti-reflux versus conventional self-expanding metal stents in the palliation of esophageal cancer: A systematic review and meta-analysis.
Sasso JGRJ; de Moura DTH; Proença IM; Junior ESDM; Ribeiro IB; Sánchez-Luna SA; Cheng S; Bestetti AM; Kum AST; Bernardo WM; de Moura EGH
Endosc Int Open; 2022 Oct; 10(10):E1406-E1416. PubMed ID: 36262514
[No Abstract] [Full Text] [Related]
17. A pilot study of fully covered self-expandable metal stents prior to neoadjuvant therapy for locally advanced esophageal cancer.
Lopes TL; Eloubeidi MA
Dis Esophagus; 2010 May; 23(4):309-15. PubMed ID: 19788439
[TBL] [Abstract][Full Text] [Related]
18. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial.
Kitano M; Yamashita Y; Tanaka K; Konishi H; Yazumi S; Nakai Y; Nishiyama O; Uehara H; Mitoro A; Sanuki T; Takaoka M; Koshitani T; Arisaka Y; Shiba M; Hoki N; Sato H; Sasaki Y; Sato M; Hasegawa K; Kawabata H; Okabe Y; Mukai H
Am J Gastroenterol; 2013 Nov; 108(11):1713-22. PubMed ID: 24042190
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of self-expanding metal stents in patients with inoperable esophageal cancer: a real-life study.
Jiménez-Gutiérrez JM; Alonso-Lárraga JO; Hernández-Guerrero AI; Lino-Silva LS; Olivas-Martinez A
Ther Adv Gastrointest Endosc; 2023; 16():26317745231200975. PubMed ID: 37771789
[TBL] [Abstract][Full Text] [Related]
20. Fully vs. partially covered selfexpandable metal stent for palliation of malignant esophageal strictures: a randomized trial (the COPAC study).
Didden P; Reijm AN; Erler NS; Wolters LMM; Tang TJ; Ter Borg PCJ; Leeuwenburgh I; Bruno MJ; Spaander MCW
Endoscopy; 2018 Oct; 50(10):961-971. PubMed ID: 29895072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
